[Treatment of a patient with carcinoid syndrome with SMS-201-995 (octreotide) for 32 months].
Marcos Sánchez
F
F
Juárez Ucelay
F
F
Plaza Díaz
R
R
García Camba
L
L
Durán Pérez-Navarro
A
A
D005260:Female; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*
D015282:Octreotide
Tratamiento de un paciente con síndrome carcinoide con SMS-201-995 (octreotide) durante 32 meses.